Search

Search Results
Results 3351 - 3360 of 9445 for emergency medicine
  • Drug - 12 Jan 2023
    Consumer Medicine Information (CMI) about Abacavir/Lamivudine Viatris intended for persons living in Australia.
  • News - 7 Dec 2022
    Nearly every person in the United States has been exposed to per- and polyfluorinated alky substances (PFAS) at some point in their life.
  • Drug - 7 Dec 2022
    Consumer Medicine Information (CMI) about Axotide Accuhaler intended for persons living in Australia.
  • Drug - 7 Dec 2022
    Consumer Medicine Information (CMI) about Avamys intended for persons living in Australia.
  • Drug - 6 Dec 2022
    Consumer Medicine Information (CMI) about Entresto intended for persons living in Australia.
  • News - 1 Dec 2022
    Children and teens who survive a firearm injury have a high rate of developing new mental health diagnoses in the year afterward, even compared with kids who suffered injuries in a motor vehicle...
  • News - 29 Nov 2022
    Continuity of care is essential to the clinician/patient relationship within family medicine. However, researchers have few ways to track continuity of care as a measurement of clinical quality.
  • Drug - 23 Nov 2022
    Consumer Medicine Information (CMI) about Erivedge intended for persons living in Australia.
  • News - 10 Nov 2022
    An intervention that teaches patients in addiction treatment how to better connect with their primary care medical team on both mental and physical health concerns resulted in long-term benefits over...
  • Drug - 8 Nov 2022
    Consumer Medicine Information (CMI) about Xalkori intended for persons living in Australia.

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.